Gout therapeutics market value U.S. by drug type 2015-2025

This statistic shows the value of the gout therapeutics market in the United States from 2015 to 2025, by drug type. In 2015, urate lowering agents to treat gout were worth nearly 270 million U.S. dollars. It is forecasted that it will exceed 1.3 billion U.S. dollars by 2025.

Gout therapeutics market in the U.S. from 2015 to 2025, by drug type

Drug typeUrate lowering agentsColchicineCorticosteroidsNSAIDs*
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2019


United States

Survey time period

March 2017

Supplementary notes

* Non-steroidal anti-inflammatory drugs.
** Figures from 2016 on are forecasts.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Arthritis and rheumatic diseases in the U.S."

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.